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In the mouse blastocyst, epiblast cells are newly formed shortly before
implantation. They possess a unique developmental plasticity, termed naive
pluripotency. For development to proceed, this naive state must be subsumed
by multi-lineage differentiation within 72 h following implantation. In vitro
differentiation of naive embryonic stem cells (ESCs) cultured in controlled con-
ditions provides a tractable system to dissect and understand the process of
exit from naive pluripotency and entry into lineage specification. Exploitation
of this system in recent large-scale RNAi and mutagenesis screens has uncov-
ered multiple new factors and modules that drive or facilitate progression out
of the naive state. Notably, these studies show that the transcription factor net-
work that governs the naive state is rapidly dismantled prior to upregulation
of lineage specification markers, creating an intermediate state that we term
formative pluripotency. Here, we summarize these findings and propose a
road map for state transitions in ESC differentiation that reflects the orderly
dynamics of epiblast progression in the embryo.1. Introduction
The epiblast is the founder tissue that gives rise to the entire fetus in amniotes. The
mouse epiblast segregates as a group of 10–20 cells within the inner cell mass
(ICM) of the mature blastocyst around embryonic day (E) 4.0–4.5. Each epiblast
cell is considered fully capable of engendering all lineages of the fetus: ectoderm,
endoderm, mesoderm and germline. This state of broad developmental plasticity
has been called ‘naive pluripotency’ [1]. Epiblast cells isolated at this transitory
stage of development can self-renew ex vivo and be propagated as cell lines that
are called embryonic stem cells (ESCs) [2,3]. Mouse ESCs (mESCs) retain the plur-
ipotent character of the naive epiblast; after extended passaging, clonal cultures
can still differentiate into multiple cell types in vitro. Furthermore, when intro-
duced into a preimplantation host embryo, they can re-integrate into the
developmental programme and contribute to all lineages including the germline
to form healthy chimaeric animals.
Emergence of more than 200 specialized cell types in the body from a small
number of equivalent cells is a fascinating process and presents a number of
fundamental questions to developmental biologists: (1) How is naive pluripo-
tency established? (2) How does pluripotency evolve to enable differentiation?
(3) How are lineage decisions made? Here, we focus on the second question,
namely, the exit from naive pluripotency and approach to differentiation.
In the mouse embryo, germ layer specification begins in the postimplantation
epiblast prior to the onset of gastrulation (E6.5). In the postimplantation period,
epiblast cells may go through a series of transitions that progressively channel
them to specific fates. Gene expression and immunostaining data demonstrate
that the preimplantation and postimplantation epiblast have distinct gene
expression profiles. Many genes have also been identified whose mutation dis-
rupts the egg cylinder or germ layer formation. However, from these data alone
it is difficult to deduce causative molecular mechanisms that drive transitions
in the epiblast population. Elucidation of these mechanisms in the embryo
requires the combination of ‘omic’ approaches with technologies for temporally
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reporters of gene expression and signalling pathway activity.
These types of studies are limited by poor accessibility of
peri- and postimplantation stages in utero, sub-optimal devel-
opment of early postimplantation embryos ex vivo and
low cell numbers for high-throughput molecular analyses
such as proteomics or chromatin immunoprecipitation
(ChIP). Alternatively, transitions in the epiblast may be
probed using embryo-derived cell lines provided that an exper-
imental setting is established that can reasonably recapitulate
in vivo development. ESCs provide the foundation for such
approaches. In particular, when cultured in defined conditions
known as 2i/LIF, ESCs substantially preserve features of the
naive preimplantation epiblast. 2i/LIF comprises serum-free
medium in which two selective inhibitors (2i) block mitogen-
activated protein kinase (MEK) and glycogen synthase kinase
3 (GSK3) activity and the cytokine leukaemia inhibitory
factor (LIF) activates the Stat3 pathway [4–6]. ESCs in 2i/LIF
can be used as surrogates of the naive epiblast and interroga-
ted experimentally to uncover molecular mechanisms that
govern naive pluripotency and orchestrate transitions towards
lineage-restricted cell states.
In this review, we first summarize the progression of the
naive epiblast towards a lineage-restricted state during
embryonic development. We highlight evidence that ESCs cul-
tured in 2i/LIF are authentic in vitro counterparts of the naive
epiblast and consider postimplantation epiblast-derived
stem cells (EpiSCs) and postimplantation epiblast-like cells
(EpiLCs) models in comparison with embryonic populations
in vivo. We then focus on the exit from naive pluripotency
and summarize recent large-scale RNAi and insertional muta-
genesis screens that have uncovered candidate factors and
molecular mechanisms that drive or consolidate the transition
into lineage specification. We also expose and challenge three
interlinked notions prevalent in current thinking about dif-
ferentiation of ESCs: (i) that ESCs directly differentiate into
germ layers; (ii) that heterogeneous gene expression prepares
ESCs for lineage specification; and (iii) that pluripotency fac-
tors also act as lineage specifiers. We argue that these
propositions are inconsistent with observations of epiblast pro-
gression in the embryo and of defined differentiation of ESCs in
vitro. Finally, we present a roadmap for epiblast development
and propose an intermediate phase of formative pluripotency.2. Transition from naive pluripotency to lineage
specification in the embryo
Between embryonic day 4 and 5, themouse ICM segregates into
two compartments: the naive epiblast and the hypoblast or
primitive endoderm (PrE). The epiblast subsequently develops
into the embryo proper, whereas PrE gives rise to extraembryo-
nic yolk sac tissues. Naive epiblast cells have several distinctive
features. Notably, they can be transferred between embryos
and contribute to all lineages in chimaeric mice. They can also
self-renew when placed in culture in 2i/LIF, conditions in
which Erk/MAPK signalling is completely inhibited. Both of
these features are lost upon implantation consistent with a
state transition [7]. The naive epiblast expresses general pluripo-
tency factors Oct4, Sox2 and Sall4, but is distinguished from
postimplantation epiblast by a suite of transcription factors
including Nanog, Klf2/4/5, Tfcp2l1, Tbx3, Esrrb and Rex1
(gene name: Zfp42) (figure 1a,c) [7,9,10]. The latter are callednaive markers. Shortly after implantation, the amorphous
epiblast undergoes a morphogenetic transformation into a
columnar epithelium that in rodents assumes a cup-shape
known as the egg cylinder. Molecular landmarks of this tran-
sition are suppression of naive markers and upregulation of
Fgf5 expression [7,11]. Oct4 and Sox2 continue to be expressed
uniformly throughout the epiblast with no significant change
in levels until the onset of gastrulation [12]. Importantly,
lineage-specific genes such as T, Foxa2 and Cer are not initially
expressed in the egg cylinder [7] (figure 1a,c). Subsequently,
the postimplantation epiblast starts to become regionalized on
day 7 in response to localized expression of secreted factors
Nodal, Wnt3 and Bmp4, and their antagonists such as Cer1
and Lefty1 [13]. Signalling pathways and transcription factors
downstream of these factors orchestrate formation of lineage-
specific gene expression patterns [14], and epiblast cells at the
primitive streak stage are considered to be ‘primed’ for lineage
commitment [1]. An important conclusion from these obser-
vations is that loss of naive pluripotency upon implantation
precedes lineage priming. Gene expression analyses indicate
that the immediate postimplantation epiblast is devoid of both
naive pluripotency factors and lineage-specifying factors [7].
Acquisition of lineage specification occurs over the subsequent
24–48 h implying that the epiblast undergoes further transitions
during this time.3. Capture of naive pluripotency in vitro
Originally mESCs were derived and cultured in media contain-
ing fetal calf serum (FCS) and on feeder layers of mitotically
inactivatedmouse fibroblasts. Over time, feeders were replaced
withLIFand todaymost commonlyusedmedia includeLIFand
10–15% FCS, although feeders are still widely used. Impor-
tantly, however, ESCs lines that can be efficiently derived and
maintained in LIF and serum (LS) are largely from the 129
inbred mouse strain. Moreover, mESC populations in LS with-
out feeders are mosaic [15–19]; individual cells express
significantly different levels of naive pluripotency genes and
somecells are devoid of naivemarkerexpression. These cultures
also express various lineage-specific genes in a heterogeneous
manner indicating that a proportion of cells undergo priming
and/or differentiation in response to the complex mix of
serum components. It has been proposed that ‘metastability’,
encompassing heterogeneous expression of lineage-specific
genes and pluripotency factors simultaneously across the
culture, reflects an inherent fluidity of the pluripotent state
andunderpins pluripotencybypreparingESCs for lineage com-
mitment [20,21]. However, this mode of fluctuating gene
expression has not been persuasively demonstrated in vivo,
neither in the naive epiblast nor during postimplantation
epiblast stages. In particular, germ layer markers are not coinci-
dent with naive markers. Moreover, in our experience the
variance in gene expression and level of spontaneous differen-
tiation in LS cultures is strongly influenced by serum batch,
cell density, feeder cells and genetic background. Therefore,
we consider that ESC heterogeneity is a result of sub-optimal
culture conditions and does not recapitulate epiblast behaviour
in vivo. Furthermore, heterogeneity and partial differentiation
of starting ESC cultures compromises attempts to chart
developmental progression during in vitro differentiation.
The advent of 2i culture in 2008 has changed the picture
[5]. 2i/LIF enables ESC derivation from all mouse and
implantation
naive formative primed
2i withdrawal
Rex1+ Rex1–
E4.5 E5.5 E6.5
ectoderm
endoderm
mesoderm
germ cells
(a)
(b)
(c) Nanog, Klf2/4/5,
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Figure 1. Progression from naive to primed pluripotency. (a) Progression of epiblast development in the mouse embryo and corresponding conceptual pluripotent
stages. The mature blastocyst comprises three cell lineages: naive epiblast (dark blue), PrE (green) and trophoblast (grey). By E6.5 lineage priming has commenced.
Ectoderm, blue; mesoderm, red; definitive endoderm, orange; germline, brown (adapted from Najm et al. [8]). (b) Progression of naive ESCs to a lineage primed
state upon 2i withdrawal. Rex1 is asynchronously downregulated and exit from the naive state is marked with loss of Rex1. These Rex1-negative cells might
resemble the early postimplantation epiblast, the intermediate formative stage from which lineage-specified cells emerge. (c) Expression periods of naive, early
postimplantation and priming factors together with Oct4 and Sox2 during pluripotency transitions.
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epiblast cells with high efficiency [7]. We infer that preimplan-
tation epiblast cells can convert seamlessly into ESCs in 2i/LIF
conditions. Moreover, gene expression profiles and DNA
hypomethylation states of ESCs in 2i/LIF are similar to pre-
implantation naive epiblast cells [7,26,27]. These findings
suggest that 2i/LIF may provide a signalling environment
similar to that experienced by the epiblast in the blastocyst,
thereby allowing direct capture and preservation of naive
pluripotency in vitro. Indeed, naive epiblast cells in the
embryo express little or no FGF receptor [7,10,28], rendering
these cells unresponsive to the major MEK/ERK stimulus
Fgf4 [29]. Nonetheless, it would be informative to examine
activity of MEK/ERK signalling directly by immunostaining
for active, phosphorylated ERK and by measuring expression
of MEK/ERK transcriptional targets.
Although combination of LIF with the 2i inhibitors maxi-
mizes the efficiency of ESC derivation and clonogenicity of
established ESCs, for most ESC lines any two of these three
components is sufficient to maintain the naive state [6,30].
Importantly, ESC populations show substantially uniform
expression of key pluripotency factors under each of these
conditions, and the heterogeneity and spontaneous differen-
tiation that is characteristic of ESCs cultured without
inhibitors or feeder cells in LIF and serum is eliminated
[16]. Differentiation of naive ESCs is rapidly initiated when
2i/LIF components are removed, driven by high autocrine
expression of Fgf4 [16,30–33]. Efficient progression of naive
ESCs into all lineages despite lacking lineage priming ordynamic pluripotency factor expression seems difficult to
reconcile with an obligate role for metastability, or dynamic
heterogeneity, in pluripotency.4. Tracking exit from naive pluripotency using
the Rex1 : GFPd2 reporter
Although naive ESC cultures in 2i/LIF are rather homo-
geneous, their differentiation is not synchronized. To monitor
early phases of differentiation, we adopted Rex1 (Zfp42)
as a neutral read-out of naive pluripotency because of its
known downregulation after implantation [7,11] and because
homozygous deletion of Rex1 has no phenotypic consequence
for ESCs or the mouse embryo [34,35]. We generated a
Rex1:GFPd2 knockin reporter ESC line, in which expression
of destabilized green fluorescent protein with a half-life of
2 h (GFPd2) is driven by the endogenous Rex1 promoter [4].
This reporter enables near real-time monitoring and frac-
tionation of early differentiation stages in ESCs by flow
cytometry. In monolayer 2i culture with or without addition
of LIF, Rex1:GFPd2 shows tight unimodal expression
[30–33]. Uponwithdrawal of inhibitors, Rex1 : GFPd2 is down-
regulated in an asynchronousmanner resulting in a substantial
proportion of Rex1-negative cells in fully defined conditions
without exogenous inducers. This occurs within 24 h when
beginning with ESCs in 2i. Presence of LIF in the starting cul-
ture delays the emergence of Rex1-negative cells by more
than 12 h because LIF confers additional stability to the naive
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epiblast cells and differentiating ESCs strongly correlates with
loss of clonogenicity in 2i/LIF [7,16] (T. Kalkan 2014, unpub-
lished data), indicating that downregulation of Rex1 marks
irreversible exit from the naive state. Pluripotency transitions
in ESCs based on Rex1 : GFPd2 expression are depicted in
figure 1b. Expression of Rex1 : GFPd2 has been used as a
proxy of the naive state in recent RNAi and mutagenesis
screens designed to identify the drivers of entry into differen-
tiation [32,33]. Persistent self-renewal capacity of mutated
ESCs that failed to downregulate the reporter in these screens
has further corroborated Rex1 expression as a reporter of the
naive state [32]. Notably, expression levels of other naive mar-
kers such as Nanog, Klf2 and Tfcp2l1 start to decline much
earlier than Rex1, approximately 4 h after inhibitor withdrawal
[32], yet self-renewal capacity is fully retained as long as Rex1 is
maintained (T. Kalkan 2014, unpublished data). Thus, downre-
gulation of key transcription factors such as Nanog, Klf2 or
Tfcp2l1 is not sufficient for exit of ESCs from the naive state.
This is consistent with previous evidence that a proportion of
ESCs that have downregulated Nanog in LS are able to revert
to a Nanog-positive state and remain undifferentiated [17,36].
As homozygous deletion of Rex1 is inconsequential for ESC
self-renewal and the naive epiblast, we infer that coincidence
of Rex1 downregulation with loss of naive state self-renewal
is not due a critical function for Rex1 in the naive state. It
most probably reflects the cumulative loss of positive transcrip-
tional input from naive pluripotency factors on the Rex1 gene
regulatory regions [37]. Additionally, accumulation of a tran-
scriptional repressor might impede Rex1 expression.
Fractionation of differentiating Rex1 : GFPd2 ESCs by
flow cytometry might provide an opportunity to isolate
emerging Rex1-negative ESCs which are close to the point
of exit from the naive state. Characterization of fractionated
ESCs at different time points along the differentiation time
course might illuminate the order of early molecular tran-
sitions in the naive epiblast. In addition, to what extent
the early Rex1-negative population resembles the newly
implanted or intermediate epiblast is of great interest.5. Generation of postimplantation epiblast
in vitro: EpiSCs and EpiLCs
The egg cylinder can also give rise to stem cell lines, which are
called postimplantation epiblast-derived stem cells (EpiSCs).
These cell lines can be derived from a range of postimplanta-
tion stages (E5.5 to E8) using basal medium supplemented
with activin, Fgf2 with optional addition of KSR (knockout
serum replacement) and feeders [38–41]. Since their first deri-
vation in 2007, EpiSCs have been proposed as in vitro
counterparts of the postimplantation epiblast. EpiSCs express
Oct4 and Sox2, but do not express naive pluripotency factors
except for Nanog. By contrast, they express the early post-
implantation epiblast marker Fgf5, as well as lineage-specific
factors, such as T, Foxa2 and Cer. However, these genes are
expressed in a highly heterogeneous manner [38,42]. EpiSCs
have been shown to retain functional properties of the post-
implantation epiblast, in that they can be differentiated
to somatic lineages in vitro and in teratomas. EpiSCs can also
colonize somatic lineages to some extent when injected into
postimplantation stage embryos in vitro [38,43], though not
when introduced into preimplantation embryos. Thesedifferentiation assays have not been performed using single
cells, and recent evidence suggests that EpiSCs comprise a
mixed population of lineage progenitors cells along with
pluripotent precursors [44].
EpiSCs can also be generated from ESCs by differentiation
in the continuous presence of activin and Fgf2 [45]. However,
stable EpiSC cultures are obtained only after passaging and the
process is accompanied by heterogeneous differentiation and
cell death. This suggests that ESCs do not directly convert
into EpiSCs, but that a divergence from the normal differen-
tiation path is required. In line with this idea, a recent study
which compared several independently derived EpiSC lines
to different postimplantation epiblast stages revealed that the
transcriptome of EpiSC lines was variable but resembled
most closely late gastrulation stage epiblast, regardless of the
original embryo stage from which the cell lines were derived
[38]. Induction of the EpiSC state by culture components is
further indicated by derivation of EpiSCs from blastocyst
explants [46]. When injected into postimplantation stage
embryos, EpiSCs most efficiently integrate in the anterior
primitive streak. Overall, their heterogeneity, late epiblast
characteristics, and protracted derivation from ESCs reduce
the utility of EpiSCs for studying pluripotent transitions.
However, transitional cells with similarities in gene
expression profile to early postimplantation epiblast (E5.5)
have been identified during differentiation of ESCs. These post-
implantation epiblast-like cells (EpiLCs) are transient and form
from naive ESCs at around 48 h after withdrawal of 2i/LIF and
addition of EpiSC medium containing KSR [8,47]. EpiLCs do
not exhibit naive pluripotency gene expression, but express
early postimplantation epiblast markers such as Fgf5, Otx2
and Oct6 along with Oct4 and Sox2. Transcriptome profiling
places them close to the early postimplantation epiblast and
distinguishes them from EpiSCs which express later lineage
markers. Consistent with this identity, and unlike EpiSCs,
EpiLCs can be differentiated efficiently to primordial germ
cells and give rise to functional gametes, a property of the
pre-gastrulation intermediate epiblast [47–49].6. The molecular route to exit from the naive
embryonic stem cell state
The naive state of ESCs and the preimplantation epiblast is
characterized by co-expression of a set of transcription factors
called the ‘naive pluripotency factors’ (figure 1c). These naive
factors together with Oct4 and Sox2 constitute the trans-
criptional control circuitry of the naive state [7,16,30]. The
network is maintained cooperatively through cross-regulation,
generating a self-reinforcing regulatory circuit when insulated
from MEK/ERK and GSK3 activity. LIF confers additional
robustness to the network through upregulation of Tfcp2l1
and Klf4 [19,50,51]. When ESCs maintained in 2i without LIF
are withdrawn from inhibitors, a decline in transcript levels of
naive factors is evident from as early as 4 h [32]. Naive pluri-
potency factor expression is largely eliminated within 24 h and
the network is eliminated entirely by 48 h, accompanied by
loss of self-renewal ability in 2i/LIF [30–32]. Coincident with
dismantling of the naive pluripotency network, characteristic
markers of the postimplantation epiblast such as Fgf5, Oct6
and Otx2 are induced and de novo methyltransferases
Dnmt3a1 and Dnmt3b are upregulated (T. Kalkan 2014, unpub-
lished data). Overall, these gene expression changes appear very
Table 1. Summary of large-scale exit from naive pluripotency screens.
reference
loss-of-function
method coverage
no. of high
conﬁdence hits differentiation method
criteria for selection of
positive hits
Betschinger et al. [31] siRNA 9900 genes 28 monolayer differentiation
in N2B27 for 96 h
proliferation in 2i/LIF and
retained Oct4 expression
Yang et al. [33] siRNA genome-wide 272 monolayer differentiation
in N2B27 for 28 h/96 h
retained Rex1:GFPd2/
Oct4:GFP expression
Leeb et al. [32] haploid insertional
mutagenesis
genome-wide 113 two rounds of monolayer
differentiation in
N2B27 for 7–10 days
proliferation in 2i/LIF and
retained Rex1:GFPd2
expression
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tured ESCs by withdrawal of 2i/LIF with or without addition
of exogenous factors such as activin or Fgf2, suggesting that
the major driver of this initial transition is activity of MEK/
ERK and GSK3 [8,48]; (T. Kalkan 2014, unpublished data).
Monolayer differentiation of naive ESCs following 2i
withdrawal has been exploited in large-scale mutagenesis and
RNAi screens to find molecular drivers and facilitators of the
exit from the naive state. Hits were identified based on persist-
ence of Rex1 : GFPd2 expression, retention of self-renewal
ability in 2i/LIF, or both. The design of these screens is summar-
ized in table 1. Overall, 600 protein-coding genes have been
identified in three screens [31–33]. Interestingly, thevastmajority
of these are expressed in the naive state, with only 69 being
transcriptionally upregulated upon 2i withdrawal (T. Kalkan
2014, unpublished data). This finding indicates that many regu-
lators might be idle in the naive state owing to the absence of
active MEK/ERK and GSK3 signalling, or their functions
might be counteracted directly by naive pluripotency factors.
An implication from these data is that ESCs, and by analogy
naive epiblast cells, are intrinsically poised for developmental
progression. This may underlie the rapid transitions during
periimplantation development in rodent embryos.
Fgf4/MEK/ERK has been identified as themajor signalling
cascade that initiates ESCdifferentiation. Genetic deletion of the
secreted ligand Fgf4 or theMEK target ERK2mimicsMEK inhi-
bition and impedes ESC differentiation along multiple lineages
[52,53]. In the embryo, lack of Grb2, which couples the Fgf
receptor to the MEK/ERK pathway, or chemical inhibition of
MEK converts the entire ICM into Nanog-positive epiblast at
the expense of the hypoblast, indicating that naive pluripotency
in vivo arises in the absence of MEK/ERK signalling [54,55].
Consistent with these observations, multiple core components
of the Fgf4/MEK/ERK signalling cascade including Fgfr2,
Raf1, K-Ras, N-Ras, MEK2 and ERK1/2 were recovered in the
exit fromnaive pluripotency screens; however, downstream tar-
gets of ERK1/2 that are critical for ESCdifferentiation still await
identification. ERK1/2 have more than 200 known substrates
with diverse functions [56,57], hence multiple proteins ident-
ified in the differentiation screens are expected to be direct
phosphorylation targets of ERK1/2.
Functional examination of validated hits and candidates
emerging from the screens indicates that timely dismantling
of the naive pluripotency network and acquisition of a
postimplantation epiblast-like gene expression profile is
ensured by a combination of mechanisms acting at multiple
levels (figure 2). Below we discuss some of the majormechanisms regulating the levels of naive pluripotency fac-
tors, including transcriptional regulation, nuclear transport
and mRNA stability. We also consider an emerging mechan-
ism of transcription factor repurposing to establish new gene
expression programmes during developmental transitions.7. Repression of naive pluripotency factor
transcription
Tcf3 (gene name: Tcf7l1) is a transcriptional repressor impli-
cated in Wnt signalling and has been shown to be the main
downstream effector of GSK3 signalling in ESC differentiation.
Knockout or mutation of Tcf3 renders ESCs largely resistant to
differentiation [4,58,59]. The pivotal role of Tcf3 in exit from the
naive state has been reinforced by identification of Tcf3 as the
top hit in all three screens [31–33]. Upon withdrawal of
Chiron, derepressed GSK3 phosphorylates b-catenin and
causes its proteosomal degradation. Mechanistic studies
showed that degradation of intracellular b-catenin frees Tcf3
to exert its repressor function [60]. Naive pluripotency factors
Klf2, Nanog and Esrrb are all directly repressed by Tcf3
[4,59–61]; however, among these repression of Esrrb appears
to be the most critical for exit from naive pluripotency upon
Chiron withdrawal [61]. Interestingly, ChIP studies showed
that Tcf3 is largely localized to the same genomic loci as
Oct4 and Nanog in serum-cultured ESCs [62]. However, it is
hard to evaluate whether the three factors co-occupy these
loci simultaneously, as serum-cultured ESCs comprise cells in
different states. Nevertheless, this finding raises the possibility
that Tcf3 might be deployed to key naive pluripotency genes
together with Oct4, which might underlie its potent repressive
action upon 2i withdrawal. The recently described interaction
of Tcf3 with Oct4 in naive cells strengthens this possibility [8].
Another transcriptional repressor recovered in the recent
screens is the nucleosome remodelling and histone deacetyl-
ation (NuRD) corepressor complex. A requirement for NuRD
in early differentiation phase of ESCs and the naive epiblast
is well established [63,64]. Abolishing NuRD function through
genetic deletion of its scaffold protein Mbd3 was shown to
cause upregulation of naive pluripotency transcripts in ESCs,
with most pronounced effects on Tbx3 and Klf4 [65].
Consequently, Mbd3-null ESCs exhibit less spontaneous differ-
entiation in LS and can self-renew in the absence of LIF. When
injected into blastocysts, these cells do not contribute to post-
implantation development. Mbd3-null embryos fail shortly
after implantation consistent with a requirement for NuRD
naive
pluripotency
transcriptional repressors
Tcf3 [31–33]
NuRD [32,33]
PRC1/2 [31–33]
regulators of nuclear
transport
folliculin [31]
exportin1 [32,33]
importin 5/9 [32]
nucleoporins88/107/
155/188 [32,33]
regulators of mRNA
stability/translation
Pum1 [32]
transcription
factors
Otx2 [33]
Zic2 [32]
Zfp281 [31]
Figure 2. Negative regulators of naive pluripotency. In the presence of active MEK/ERK and GSK3, the naive pluripotency factors are subject to coordinated attack at
different levels: transcriptional repression, mRNA stability and translation, nuclear/cytoplasmic localization. Induced/activated transcription factors Otx2, Zic2 and Zfp281
might cooperate with these mechanisms to further suppress the levels of naive factors. They also activate new genes that mediate further developmental progression.
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findings, several components of the NuRD complex including
Mbd3, Gatad2, Mta1 and Rbbp4 were identified as candidate
factors that drive exit from the naive state in ESCs, placing
NuRD as a key transcriptional repressor required for termin-
ation of the naive pluripotency gene expression programme
(figure 2). NuRD was shown to regulate gene expression by
deacetylating lysine 27 of histone 3 (H3K27) and thereby facil-
itating polycomb repressive complex 2 (PRCR2)-mediated
trimethylation of H3K27 and associated gene repression [66].
Zfp281, a transcription factor that has been identified in
an siRNA screen [31], was proposed to recruit the NuRD
complex to the Nanog promoter through direct interaction
with Nanog and NuRD components [67–70]. Moreover,
Zfp281-null ESCs were shown to exhibit increased Nanog
and Rex1 expressions and could not be differentiated into
embryoid bodies. Zfp281-null embryos are reported to die
around E8 although the phenotype is not detailed [71].
Zfp281 thus appears to be another significant player in exit
from naive pluripotency, although its precise mode of
action merits further investigation.
Finally, epigenetic silencers, the polycomb repressive com-
plexes (PRC1 and PRC2), are implicated in exit from the naive
state. PRC1 components Phc1 and Ring1B, and PRC2 com-
ponents Ezh2, Suz12, Mtf2 (Pcl2) and the PRC2-associated
protein Jarid2 were recovered in the screens (figure 2). PRC1
and PRC2 secure transcriptional repression by introducing
chromatin compaction through mono-ubiquitylation of lysine
119 of histone 2A (H2AK119ub) and trimethylation of lysine
27 of histone 3 (H3K27me3), respectively [72]. Single and
double knockout of these complexes demonstrated that they
function semi-redundantly in ESCs [73]. While knockout of
either PRC1 or PRC2 by genetic deletions of their respective
core catalytic enzymes, Ring1B and Ezh2, only mildly affected
self-renewal or differentiation of ESCs, Ring1B/Ezh2 doublenull ESCs could not execute differentiation. Notably, these
cells were able to self-renew, suggesting that the critical role
of PRC complexes is during early differentiation. This prop-
osition is now further strengthened by failure of cells that are
compromised in PRC activity to exit the naive state efficiently
in the genetic screens. Consistent with this, the number of
genes marked with H3K27me3 and the intensity of this repres-
sive histone mark is significantly reduced in naive ESCs
compared with LS-cultured ESCs without an apparent differ-
ence in expression of PRC2 components [16], suggesting that
H3K27me3 marks are associated with differentiating cells in
LIF/serum and PRC2 activity might be enhanced downstream
of active MEK/ERK and GSK3 signalling to secure timely exit
from the naive state.8. Control of naive pluripotency factor
transcription via nuclear/cytoplasmic
transport
In addition to direct repression by Tcf3, transcription of the
potent naive pluripotency factor Esrrb is further reduced by
the activity of the folliculin/Fnip complex. The unexpected
role of folliculin/Fnip emerged from an siRNA screen [31].
This complex regulates subcellular localization of the basic
helix-loop-helix transcription factor Tfe3, which was shown
to bind to Esrrb cis-regulatory regions together with Oct4
and Nanog and contribute to positive regulation of Esrrb
transcription. In naive ESCs, Tfe3 protein is distributed in
both the nucleus and cytoplasm, but upon 2i withdrawal,
nuclear Tfe3 is sequestered in the cytoplasm in a manner
dependent on folliculin/Fnip. Thus, access of Tfe3 to its tran-
scriptional targets, notably Esrrb, is prevented. Importantly,
Tfe3 protein is excluded from the nuclei of epiblast cells
rstb.royalsocietypublishing.org
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likely to be operation in vivo. It is not known how the activity
of folliculin/Fnip complex is regulated downstream of MEK/
ERK and GSK3, although mTOR clearly plays a role [31]. Nor
is it clear how folliculin/Fnip causes nuclear exclusion of
Tfe3. However, recovery of factors with roles in nuclear/cyto-
plasmic transport in the loss-of-function screens suggests that
selective nuclear import and export of transcription factors
might be a more general mechanism that regulates exit
from the naive state (figure 2). Moreover, it has been shown
that 2i/LIF withdrawal induces auxetic properties in the
nuclei of naive ESCs, meaning the nuclei increase in
volume when stretched and stiffen when compressed under
physical forces [74]. This structural change was found to be
associated with chromatin decondensation; however, it
might also impact on the rates of simple diffusion and selec-
tive nuclear/cytoplasmic transport of signalling molecules to
affect exit from the naive state. 9:201305409. Stability of naive pluripotency factor
transcripts
Reduction in the levels of naive pluripotency factor mRNAs is
remarkably rapid, declining by 70% only 4 h after 2i withdra-
wal. This fast response suggests that mechanisms other than
transcriptional control at the promoter level may play a role.
Consistent with this idea, Pum1, which is an RNA-binding
protein that inhibits translation and promotes degradation of
target mRNAs [75,76], was identified in an insertional muta-
genesis screen [32]. Pum1 knockdown in ESCs impaired exit
from the naive state and delayed downregulation of transcripts
for Tfcp2l1, Klf2, Tbx3, Esrrb, Sox2 and Nanog [32]. Impor-
tantly, Pum1 was found to physically interact with mRNAs
for naive factors. Thus, Pum1 most probably directly promotes
their degradation upon 2i withdrawal and potentially also
inhibits translation. Furthermore, Pum1 activity appears to
be constitutive because in 2i conditions it is bound to its
target mRNAs and knockdown leads to mild upregulation.
Hence, constitutive function of Pum1 might constrain self-
renewal in addition to ensuring rapid elimination of
translation and clearance of transcripts when transcription is
reduced. Whether Pum1 activity is further enhanced in
response to MEK/ERK and GSK3 is currently not known. In
either case, it seems that Pum1-mediated mRNA degradation
is a further mechanism that ensures rapid dissolution of the
naive pluripotency network. It will be interesting to see if
this mechanism is reused in other cell fate transitions.10. Initiation of a new transcription programme
As the naive pluripotency network is dissolved within the 48 h
following 2i/LIF withdrawal, hundreds of new genes are
induced and the cells acquire a transcription profile resembling
early postimplantation epiblast [8,33,47]. An unresolved ques-
tion is how cells initiate a new transcription programme. Is
dismantling of the naive pluripotency network sufficient for
activation of the differentiation programme if some of the
naive factors directly repress differentiation-associated genes?
Or does this process require recruitment of new transcription
factor complexes to gene regulatory regions that are activated
during the transition? Recent studies shed some light ontothese questions by showing that Oct4 and transcription factors
induced early upon 2i withdrawal, such as Otx2, cooperatively
induce new gene expression during the transition [8,77]. Both
Oct4 and Otx2 were recovered in an siRNA screen as candi-
date factors to drive exit from the naive state [33]. Oct4 was
previously implicated in early differentiation because cells
with reduced levels of Oct4 failed to differentiate efficiently
and showed enhanced self-renewal [78,79]. Otx2 was also
reported to be required for early differentiation of ESCs and
conversion to EpiSCs as well as for postimplantation develop-
ment [80,81]. Building on these observations, recently two
independent studies uncovered a mechanistic link between
Oct4 and Otx2 which delineates one of the routes ESCs use
to initiate a new gene expression profile upon MEK/ERK
and GSK3 activation [8,77]. The principal finding of these
studies is that Otx2 is rapidly induced after 2i withdrawal
and recruits Oct4 to enhancers that are associated with genes
induced during differentiation. Moreover, both studies impli-
cate Otx2 in the activation of these enhancers. Importantly,
in the EpiLC differentiation protocol, Oct4 was found to inter-
act with different sets of transcription factors and chromatin
modifiers in the naive state and in EpiLCs, while other inter-
action partners, such as Sox2, were common in both states
[8]. In the naive state, Oct4 pull-down complexes contained
Tcf3, Esrrb and Klf5, whereas in EpiLCs, Oct4 was found to
co-purify with Otx2, Zic2/3, Oct6, Zfp281 and Zscan10 [8].
Thus, Oct4 is likely to function in different transcription
factor complexes that are specific to the naive and EpiLC
states. Notably, two Oct4-interacting proteins specific to
EpiLCs, Zic2 and Zfp281, were also identified in the exit
from pluripotency screens [31,32], suggesting that Oct4
might engage with these proteins in a fashion similar to its
partnership with Otx2 to affect new transcription. Oct4 partner
switch may be dictated by the relative levels of potential Oct4
partners in a cell. As a way of example, in the naive state Esrrb
is highly expressed and Otx2 is low; therefore, by simple mass
action Oct4 may be more likely to form a protein complex with
Esrrb. Upon 2i withdrawal, Esrrb is downregulated and Otx2
is induced which may favour formation of Oct4–Otx2 com-
plexes. Such an Oct4 partner switch can result in differential
enhancer selection, as has been demonstrated by artificially
modulating the levels of two Sox family transcription factors,
Sox2 and Sox17, both of which can interact with Oct4 [82].
Differential partner interaction may account for the Oct4 over-
expression phenotype. Upregulation of Oct4 was reported to
cause mesoendodermal differentiation in LS-cultured ESCs,
and to accelerate neural differentiation in serum-free LIF-
deficient medium [83,84]. These observations together with
persistence of Oct4 and Sox2 during early differentiation sub-
sequently led to the proposal that these transcription factors
act as lineage specifiers [85]. Furthermore, differentiation phe-
notypes associated with Sox2 and other pluripotency factors in
mouse and human ESCs led to a hypothesis that all pluripo-
tency factors are lineage specifiers and pluripotency is a
precarious balance between opposing lineages [86]. However,
some of the observations behind this hypothesis can be
explained by promiscuous partner selection by Oct4. In differ-
entiation permissive medium such as LS, in which
differentiation-associated partners of Oct4 such as Otx2 and
Sox17 are expressed, overexpression of Oct4 might increase
interactions with these factors and promote differentiation.
However, as such partners are not expressed in the naive
state, moderate overexpression of Oct4 in 2i/LIF may be
rstb.royalsocietypublis
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estingly, Sox2 was also identified as a factor required for exit
from the naive state [31], raising the possibility that like
Oct4, Sox2 might switch partners to promote differentiation.
Both Oct4 and Sox2 continue to be expressed at the post-
implantation stages and here they are likely to play roles in
lineage specification. Whether these are really opposing
remains to be experimentally validated. hing.org
Phil.Trans.R.Soc.B
369:2013054011. Discussion and conclusion
More than 600 proteins have been implicated in exit from the
naive state. Here, we have discussed only a handful, primarily,
of those whose function has been independently validated.
However, this limited set is sufficient to reveal the variety of
the mechanisms that control early state transitions in ESCs
and complexity of the regulation. Investigation of further can-
didates will expand our understanding in this area and may
facilitate efforts in deriving naive ESCs from non-rodent
species, including humans. The fact that these actors are
revealed upon 2i withdrawal but are mostly present in the
naive state suggests that ESCs cultured in LIF/serum are
likely to be continuously challenged owing to active MEK/
ERK and GSK3 signalling induced by undefined serum
components in addition to autocrine Fgf4. In this light, the
widely commented upon heterogeneity of ESCs in LS appears
to be a response to an incoherent signalling context, in which
the naive pluripotency circuitry is constantly confronted with
differentiation stimuli. We contend that the defined 2i/LIF cul-
ture system for ESCs provides a more appropriate and accurate
reflection of naive epiblast in the embryo. ESC differentiation
after 2i/LIF withdrawal mimics orderly transitions of the
naive epiblast upon implantation and provides a relevant
simulation of the early lineage specification process. Elucida-
tion of regulatory mechanisms that redeploy Oct4 during thetransition confirms that the central element of pluripotency
drives developmental progression, and hence reliable capture
of the naive state requires LIF reinforced by MEK/ERK and
GSK3 inhibition [7,30].
Presence of naive pluripotency factors appears to create
and enforce an unrestricted state in the pre-implantation epi-
blast and ESCs. Clearance of these factors subsequent to
implantation in utero or withdrawal of 2i/LIF in vitro paves
the way for differentiation. Upon downregulation of naive
pluripotency factors, pluripotent cells become receptive to
differentiation stimuli and exhibit competence to form all
somatic lineages and the germline. We propose that this for-
mative state devoid of both naive factors and lineage
specifiers is a necessary predecessor to orderly lineage speci-
fication. Figure 1 depicts this conceptual framework in which
the direct successor of naive pluripotency is a state of ‘forma-
tive pluripotency’ enabled for lineage priming. EpiLCs and
Rex1-negative cells generated by monolayer differentiation
without exogenous factors appear related to this intermediate
stage. Although information is currently limited on the hom-
ogeneity of these populations, refined culture conditions and
fractionation via reporter systems might yield populations
representative of formative epiblast. We speculate that the
absence of inhibition by naive factors and of bias introduced
by lineage specifiers may render epiblast cells optimally
receptive for homogeneous and efficient differentiation into
any embryonic lineage. Accordingly, it would be of great
interest to capture and propagate cells in such a state of
formative pluripotency.
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